Evolocumab (Evolocumab (Repatha))
Drug Class: PCSK9 inhibitor
Monoclonal antibody that inhibits PCSK9, dramatically lowering LDL cholesterol. Administered by injection, typically used for familial hypercholesterolemia or high-risk cardiovascular patients.
Nutrients That Evolocumab May Deplete
Long-term use of Evolocumab has been associated with lower levels of the following nutrients. This pattern data is surfaced by WePattern's clinical Knowledge Graph.
- Vitamin E
- CoQ10
Common Side Effects of Evolocumab
- Injection site reactions
- Upper respiratory infections
- Flu-like symptoms
- Muscle pain
- Fatigue
- Back pain